Assignment of Assignor's Interest

Recorded: 2019-07-15 Pages: 6

Assignors

WANG, WEIMIN

Executed: 2019-05-29

NAZEF, NAIM

Executed: 2019-05-17

BROWN, BOB DALE

Executed: 2019-05-24

Assignee

DICERNA PHARMACEUTICALS INC.

87 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MASSACHUSETTS, 02140

Covered Property (1)

Double-Stranded Nucleic Acid Inhibitor Molecules Modified with Tm-Increasing Nucleotides

Patent: 11,873,488 →

Application: 16/381,931 →

Publication: US 2019/0316125

PCT: PCT/US2019/027021 ↗

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.